/stocks — the workspaceLOADING
MADRIGAL PHARMACEUTICALS, INC. (MDGL) is a pharmaceutical preparations company. Piotroski F-Score 3/8. 9 insider Form 4 filings in the last 90 days. Next earnings projected around 2026-08-04 from MDGL's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
EOD daily bars · delayed, not real-time · data: DatabentoCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
FY ending 2025-12-31 vs 2024-12-31. original 1968 formula; calibrated on manufacturers, read financials/REITs with care
A plain-English read on MDGL plus an auto-SWOT — built from MDGL's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate MDGL using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
| Paulson & Co (John Paulson) | $728.8M | 23.4% of portfolio |
| Soergel DavidChief Medical Officer | SELL | $517K | view → |
| Levy Richard SDirector | SELL | $2.9M | view → |
| Soergel DavidChief Medical Officer | SELL | $435K | view → |
| Taub RebeccaDirector | SELL | $212K | view → |
| Huntsman CaroleChief Commercial Officer | SELL | $181K | view → |
| Kelley Shannon TGeneral Counsel | SELL | $155K | view → |
| Sibold William JohnPresident and CEO | SELL | $718K | view → |
| Dier MardiEVP and CFO | SELL | $854K | view → |
Projected from MDGL's own SEC 8-K filing history — the year-over-year reporting pattern (~50% land the exact day, ~90% within a week). No analyst estimates, no scraped calendars, nothing invented. It upgrades to a confirmed date + time the moment MDGL files its announcement.
MDGL has rallied after 5 of its last 8 earnings reports.
Each figure is one earnings reaction — how much MDGL moved from the closing price the day before a report to the close the day after. Based on its last 8 reports.
Large earnings reactions have been common.
MDGL has traded higher after most recent earnings releases.
The average is inflated by its most volatile prints (+48.0% and -19.1%).
A more typical earnings reaction has been approximately ±10.0%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-05-06 | +6.4% |
| 2026-02-19 | -11.5% |
| 2025-11-04 | +15.4% |
| 2025-08-05 | +8.3% |
| 2025-05-01 | -5.5% |
| 2025-02-26 | +8.5% |
| 2025-01-13 |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| -19.1% |
| 2024-10-31 | +48.0% |